UltraChoice® 8

This product has been shown to be effective for the vaccination of healthy cattle and sheep agaist disease caused by Cl. chauvoei , Cl. Septicum, Cl. Haemolyticum, Cl. novyi, Cl. Sordellii, and Cl. perfringens types  C and D. Duration of immunity has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov. Although Cl. perfringens type B is not a significant problem in North America, immunity is provided by the beta toxoid of type C and the epsilon toxoid of type D.

Mix well. Cattle: Aseptically administer two 2-mL doses subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (SC) under the skin. Healthy cattle should receive 2 doses administrated 4-6 weeks apart. Sheep: Aseptically administer 1 mL subcutaneously in the neck, followed by a second dose 4-6 weeks later.

Store at 2° C to 8° C. Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Contains formalin as preservative. Temporary local swelling at the injection site may occur after administration. Field reports indicate that a transient reduction in milk production may occur following vaccination. This product has not been tested in pregnant animals. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. Do not mix with other products. In case of human exposure, contact a physician.